First Trust Lunt US Factor Rotation ETF (FCTR)
34.14
+0.48 (+1.43%)
USD |
May 13, 16:59
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.65% | -0.03% | 257.57M | 64211.70 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 0.47% | 460.0% | 124.74M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Lunt Capital Large Cap Factor Rotation Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index utilizes the index provider's risk-adjusted relative strength methodology to allocate exposure to securities exhibiting either high or low levels of the characteristics associated with one of four primary investing factors: momentum, value, quality and volatility. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | First Trust |
| Prospectus Benchmark Index | |
| Lunt Capital LC Factor Rotation USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Chris Peterson | 2.78 yrs |
| Daniel Lindquist | 2.78 yrs |
| David McGarel | 2.78 yrs |
| Jon Erickson | 2.78 yrs |
| Roger Testin | 2.78 yrs |
| Stan Ueland | 2.78 yrs |
| Erik Russo | 0.33 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
12
124.74M
-25.72B
Category Low
14.89B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2021
Performance Versus Category
As of May 12, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of May 12, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | 2.35% | 214.27 | 0.75% |
| Regeneron Pharmaceuticals Inc | 2.28% | 517.00 | 1.94% |
| Biomarin Pharmaceutical Inc | 2.12% | 75.51 | -0.12% |
| Seagen Inc Ordinary Shares | 2.08% | 144.78 | 0.01% |
| Clorox Co | 1.95% | 182.67 | 0.38% |
| Splunk Inc | 1.85% | 111.92 | -3.26% |
| Merck & Co Inc | 1.59% | 78.57 | 0.73% |
| O'Reilly Automotive Inc | 1.54% | 554.80 | 1.19% |
| Gilead Sciences Inc | 1.53% | 68.80 | 2.00% |
| Viatris Inc | 1.50% | 15.96 | 1.53% |
News
Headline
Wire
Time (ET)
SA Breaking News
09/23 19:21
Business Wire
06/24 17:27
Business Wire
03/25 16:52
Business Wire
12/12 17:44
Business Wire
09/24 17:27
Business Wire
06/13 16:51
Business Wire
03/20 16:50
Business Wire
12/17 17:33
Basic Info
| Investment Strategy | |
| The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Lunt Capital Large Cap Factor Rotation Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index utilizes the index provider's risk-adjusted relative strength methodology to allocate exposure to securities exhibiting either high or low levels of the characteristics associated with one of four primary investing factors: momentum, value, quality and volatility. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | First Trust |
| Prospectus Benchmark Index | |
| Lunt Capital LC Factor Rotation USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Chris Peterson | 2.78 yrs |
| Daniel Lindquist | 2.78 yrs |
| David McGarel | 2.78 yrs |
| Jon Erickson | 2.78 yrs |
| Roger Testin | 2.78 yrs |
| Stan Ueland | 2.78 yrs |
| Erik Russo | 0.33 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-13-21) | 0.47% |
| 30-Day SEC Yield (3-31-21) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 20.54 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 12, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 7/23/2018 |
| Last Annual Report Date | 12/31/2020 |
| Last Prospectus Date | 5/3/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
SA Breaking News
09/23 19:21
Business Wire
06/24 17:27
Business Wire
03/25 16:52
Business Wire
12/12 17:44
Business Wire
09/24 17:27
Business Wire
06/13 16:51
Business Wire
03/20 16:50
Business Wire
12/17 17:33